Registry for patients after myocardial infarction treated with antiplatelet agents in Freiburg

Registry for patients after myocardial infarction treated with antiplatelet agents in Freiburg - MITAP

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00003146

Enrollment

500

Registered

2011-06-27

Start date

2011-07-15

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

I21

Interventions

Group 1: patients after myocardial infarction treated with antiplatelet agents - telephonic interview follow up after 12 and 36 months, respectively. Missing data can be obtained from the correspondin

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: NSTE-ACS or STEMI, informed consent

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
cardiovascular death, myocardial infarction, stent-thrombosis, ischemic stroke evaluated in telephonic interviews after 12 and 36 months, respectively	—

Secondary

Measure	Time frame
platelet aggregation assessed by impedance aggregometry at day 3-5 after myocardial infarction, adherence to physicians´ recommendation evaluated by telephonic interview after 12 months.	—

Countries

Germany

Contacts

Public ContactChristoph Olivier

Universitätsklinikum Freiburg Innere Medizin 3

Christoph.Olivier@Uniklinik-Freiburg.de004976127034010

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Mar 13, 2026